Physician profile
Richard Gerber
NPI 1407854599
$6,609.42
in general payments reported to CMS, 2019-2025
44 companies · $1,627 in 2025
The $1,627 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,046 · 2020: $390 · 2021: $130 · 2022: $577 · 2023: $1,259 · 2024: $1,581 · 2025: $1,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,466.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $581.80 | 2021-2025 | Impella |
| Philips North America LLC | $557.32 | 2022-2025 | (5050) Ext Holter, Extended Holter, (Br3) Coronary Other |
| E.R. Squibb & Sons, L.L.C. | $552.70 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $470.55 | 2019-2025 | |
| Abbott Laboratories | $423.93 | 2019-2025 | Aveir, Assurity, Optis |
| Novo Nordisk INC | $391.08 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $344.62 | 2019-2025 | Farxiga, Brilinta |
| Amgen INC. | $339.15 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $264.57 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $231.55 | 2024-2025 | Verquvo |
| Cardiovascular Systems INC. | $229.43 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $226.63 | 2019-2023 | Xarelto |
| Edwards Lifesciences Corporation | $193.44 | 2019-2025 | Sapien 3 Ultra Resilia, Evoque, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bayer Healthcare Pharmaceuticals INC. | $176.46 | 2021-2025 | |
| Shockwave Medical, INC | $162.96 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $147.74 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $123.06 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $108.71 | 2020-2025 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $80.21 | 2023-2024 | Inpefa |
| Cardiva Medical, INC. | $67.84 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Kiniksa Pharmaceuticals, LTD. | $67.47 | 2023 | Arcalyst |
| Inari Medical, INC. | $63.82 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Esperion Therapeutics, INC. | $62.97 | 2023-2025 | Nexletol |
| Kestra Medical Technology Services, INC. | $59.82 | 2022-2023 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $59.75 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $58.20 | 2024 | Zio Xt Patch, Zio Monitor |
| Siemens Medical Solutions USA, INC. | $57.76 | 2023 | Artis Icono Floor |
| Lundbeck LLC | $54.54 | 2019 | |
| Cordis US Corp. | $54.16 | 2023 | Mynx Control |
| Regeneron Healthcare Solutions, INC. | $53.06 | 2019 | |
| Medtronic, INC. | $50.58 | 2023-2024 | Symplicity G3 |
| Penumbra, INC. | $49.07 | 2024-2025 | Indigo System |
| Biotronik INC. | $36.79 | 2019-2024 | Amvia Edge, Biomonitor |
| Alnylam Pharmaceuticals INC. | $31.81 | 2023 | Onpattro |
| Heartflow, INC. | $30.92 | 2024 | |
| Scpharmaceuticals INC. | $23.61 | 2025 | |
| Bridgebio Pharma, INC. | $21.11 | 2025 | Attruby |
| Atricure, INC. | $16.64 | 2024 | |
| Inspire Medical Systems, INC. | $16.44 | 2023 | Inspire |
| Arbor Pharmaceuticals, INC. | $16.07 | 2019 | |
| Cleerly, INC. | $14.06 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Medtronic Vascular, INC. | $12.64 | 2019 | |
| Portola Pharmaceuticals, LLC | $12.54 | 2019 | |
| Terumo Medical Corporation | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Gerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.